Table 1.
Guidelines for administering the influenza vaccine (adapted from recommendations of the Centers for Disease Control and Prevention1)
Target groups | Timing and administration | Contraindications |
---|---|---|
People aged ≥65 years | Vaccine may be given any time during flu season | Previous anaphylactic reaction to vaccine, its components, or to eggs |
Residents of nursing homes and chronic care facilities with chronic medical conditions | Optimal time for vaccination is from October through mid-November | Acute febrile illness |
Adults and children who have chronic pulmonary or cardiovascular disorders | May be given concurrently with the pneumococcal vaccine and with other routine childhood vaccinations | Previous vaccine-related Guillain-Barre syndrome (vaccine may be justified in high risk patients) |
Adults and children with other chronic medical problems such as diabetes, renal dysfunction, or immunosuppression | Only split-virus vaccines (known as “split”, subvirion”, or “purified-surface antigen” vaccines) should be administered to children (<12 years) due to their decreased potential for febrile reactions* | |
Children and teenagers receiving long-term treatment with aspirin should receive the influenza vaccine to reduce the risk of Reye's syndrome | ||
Women in the 2nd or 3rd trimester of pregnancy during the influenza season | Should be administered intramuscularly: the deltoid is the preferred site in adults, the anterolateral aspect of thigh is preferred in infants and younger children | |
People who can transmit influenza to those who are at high risk (for example, healthcare providers, caretakers, household members) | ||
Other groups to consider include people infected with HIV, travelers to regions with known epidemics, and anyone who wishes to reduce their risk of influenza illness |
At recommended doses, the immunogenicity and side effects of split and whole virus vaccines are similar in adults.